S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 26.68 CNY -3.75% Market Closed
Market Cap: 17.7B CNY
Have any thoughts about
Shandong Pharmaceutical Glass Co Ltd?
Write Note

Operating Margin
Shandong Pharmaceutical Glass Co Ltd

19.2%
Current
17%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
19.2%
=
Operating Profit
982.9m
/
Revenue
5.1B

Operating Margin Across Competitors

Country CN
Market Cap 17.7B CNY
Operating Margin
19%
Country JP
Market Cap 6.8T JPY
Operating Margin
28%
Country CH
Market Cap 37.6B CHF
Operating Margin
13%
Country DK
Market Cap 179.6B DKK
Operating Margin
27%
Country US
Market Cap 15.8B USD
Operating Margin
17%
Country CN
Market Cap 52B CNY
Operating Margin
45%
Country CA
Market Cap 6.3B USD
Operating Margin
4%
Country KR
Market Cap 9.1T KRW
Operating Margin
-245%
Country US
Market Cap 6.2B USD
Operating Margin
32%
Country US
Market Cap 5.7B USD
Operating Margin
12%
Country UK
Market Cap 4.5B GBP
Operating Margin
13%
No Stocks Found

Shandong Pharmaceutical Glass Co Ltd
Glance View

Market Cap
17.7B CNY
Industry
Health Care

In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.

Intrinsic Value
45.92 CNY
Undervaluation 42%
Intrinsic Value
Price
S

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
19.2%
=
Operating Profit
982.9m
/
Revenue
5.1B
What is the Operating Margin of Shandong Pharmaceutical Glass Co Ltd?

Based on Shandong Pharmaceutical Glass Co Ltd's most recent financial statements, the company has Operating Margin of 19.2%.